Metabolomics of Type 1 and Type 2 Diabetes

Type 1 and type 2 diabetes mellitus (DM) are chronic diseases that affect nearly 425 million people worldwide, leading to poor health outcomes and high health care costs. High-throughput metabolomics screening can provide vital insight into the pathophysiological pathways of DM and help in managing...

Descripción completa

Detalles Bibliográficos
Autores principales: Arneth, Borros, Arneth, Rebekka, Shams, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566263/
https://www.ncbi.nlm.nih.gov/pubmed/31109071
http://dx.doi.org/10.3390/ijms20102467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566263/
https://www.ncbi.nlm.nih.gov/pubmed/31109071
http://dx.doi.org/10.3390/ijms20102467

Ejemplares similares